TENX vs. TPST

In the year-to-date period, TENX achieves a 8.24% return, which is significantly lower than TPST's 10.67% return. Both investments have delivered pretty close results over the past 10 years, with TENX having a -62.06% annualized return and TPST not far ahead at -60.73%.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Tenax Therapeutics, Inc. (TENX) and Tempest Therapeutics, Inc. (TPST). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current TENX Sharpe Ratio is 0.90, which is higher than the TPST Sharpe Ratio of -0.79. The chart below compares the historical Sharpe Ratios of TENX and TPST, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Neither TENX nor TPST has paid dividends to shareholders.

The maximum TENX drawdown since its inception was -100.00%, roughly equal to the maximum TPST drawdown of -100.00%. Use the drawdown chart below to compare losses from any high point for TENX and TPST. For additional features, visit the drawdowns tool.

Tenax Therapeutics, Inc. (TENX) has a higher volatility of 17.67% compared to Tempest Therapeutics, Inc. (TPST) at 12.25%. This indicates that TENX's price experiences larger fluctuations and is considered to be riskier than TPST based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between Tenax Therapeutics, Inc. and Tempest Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.